Article citationsMore>>
Ardigo, D., Assimes, T.L., Fortmann, S.P., Go, A.S., Hlatky, M., Hytopoulos, E., Iribarren, C., Tsao, P.S., Tabibiazar, R., Quertermous, T. and ADVANCE Investigators (2007) Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiological Genomics, 31, 402-409.
has been cited by the following article:
-
TITLE:
Anti eotaxin-2 antibodies attenuate the initiation and progression of experimental atherosclerosis
AUTHORS:
Adi Mor, Arnon Afek, Michal Entin-Meer, Gad Keren, Jacob George
KEYWORDS:
Atherosclerosis; Vulnerable Plaque; Inflammation; Eotaxin-2; Chemokines
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.3 No.4,
July
18,
2013
ABSTRACT: Background: The chemokine eotaxin-2 is a potent chemoattractant for inflammatory cells, the predominants of which are eosinophils. Human and murine atherosclerotic plaques are known to exhibit inflammatory phenotypes where a complex interaction of cytokine and chemokines plays a role. We tested the hypothesis that eotaxin-2 (eo-2) plays a causative role in the initiation and progression of experimental atherosclerosis. Methods and Results: Sera collected from atherosclerotic ApoE knockout (KO) mice, exhibited significantly higher levels of eo-2 compared to sera collected from their background age matched C57BL/6 litters by ELISA. Moreover, levels of eo-2 were higher in old atherosclerotic ApoE KO mice than in young animals. Similarly, the expression level of the eo-2 receptor, CCR3, was increased in splenocytes of old ApoE compared to the young littermates. Administration of polyclonal blocking antibodies to eotaxin-2 resulted in a significant reduction of early atherosclerotic plaques in ApoE KO mice whereas prolonged treatment of mice with advanced plaques led to atheroma stabilization. A monoclonal antibody (D8) prepared against eo-2 attenuated adhesion of lymphocytes to fibronectin and potently inhibited their migration towards VEGF. Monoclonal blocking antibodies to eo-2 also significantly reduced atherosclerotic plaques in ApoE KO mice. Conclusion: Eo-2 serum levels are elevated in sera of ApoE KO mice with experimental atherosclerosis and its blockade is associated with reduced fatty streak accumulation and increased plaque stabilization.
Related Articles:
-
Richard Azagoh-Kouadio, Kouakou Florent Diby, Kouadio Vincent Asse, Loa Gnaba, Koko Aude Aka-Tanoh, Kossonou Roland Yeboua, Kouassi Christian Yao, Christelle Avi, Soumahoro Oulai
-
Jai Dev Chandel, Nand Lal Singh
-
Reem Abdel Hamid Harfoush, Marwa Ahmed Meheissen, Reham Abel Haleem Abo Elwafa, Doaa Ahmed Elwazzan
-
Enas M. Abd Allah, Doaa E. El-Matary, Esraa M. Eid, Adly S. Tag El Dien
-
Lazare Kouakou Kouassi, Innocent Kouassi Kouamé, Séraphin Kouakou Konan, Brou Dibi, Soumahoro Moussa, Diakaria Koné, Dago Gnakri